Autopsy report · NCT01037764

Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)

“The PI resigned the institute, and the rest investigators at the institute decided to terminate the study.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 6 years 11 months before it stopped.
• 100 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Asan Medical Center

Sponsor type

University, hospital or other

Conditions

Acute Lymphoid Leukemia

Interventions

alloHCT

Participants

100 (planned, not actual)

Sites

2

Countries

South Korea

Trials that died the same way

• PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)
  “The study is terminated because the PI left the institution.” (82% match in meaning)
• Comparison of Quadratus Lumborum Block Types
  “PI left the institution. Decision made to close the study.” (80% match in meaning)
• Ascension® Humeral Resurfacing Arthroplasty Follow-Up Study
  “Study was terminated due to PI leaving the institution” (79% match in meaning)
• Everyday Activity Shoes: a Quantification of Impact Forces While Walking
  “The study was terminated due to the PI leaving for sabbatical.” (76% match in meaning)
• Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage
  “Study PI left the institution and study was stopped at that time.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.